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For many years, pediatric cardiologists, interventional
radiologists, and others have dreamed of and developed
methods of treating various forms of congenital heart
disease in a nonsurgical manner [1,2]. The rapid evolu-
tion of technology in the field over the last 5–10 years has
resulted in successful transcatheter treatment of a wide
range of intracardiac shunts, with excellent initial and
medium-term results and low complication rates [3–9].
Even unusual forms of congenital and/or acquired de-
fects have proven to be amenable to transcatheter inter-
vention [10,11].
Some 40 years ago, fistulous connections from the
pulmonary artery to the left atrium were described [12].
Although symptoms can occur in infancy, requiring early
intervention, this is not the typical presentation. In past
years, the treatment of this lesion has been surgical and
was associated with a high incidence of complications
[13]. In 2000, Slack et al. [14] described the first trans-
catheter closure of a right pulmonary artery to left atrial
fistula using a Gianturco coil placed into the fistulous
connection via the pulmonary artery. In this issue, Fran-
cis et al. [15] describe a slightly different technique in
which a right pulmonary artery to left atrial fistula was
closed using an Amplatzer duct occluder delivered via
the left atrium. In this patient, an associated atrial septal
defect allowed easy access to the left atrium. The duct
occluder could then be positioned such that the flange or
retention disk would be left in the pulmonary artery. The
differential pressure between the pulmonary artery and
left atrium maintained the position of the occluder. In this
case, then, the body of the occluder is left protruding into
the left atrium.
This case differs from that described by Slack et al.
[14] in that the present patient was older (12 years vs.
infancy) and was less symptomatic. They are similar in
that they both showed signs of respiratory compromise
and systemic arterial desaturation. Echocardiography
demonstrated the fistula in the newborn but failed to
show the cause of the symptoms in the older child,
possibly due to the difference in ability to visualize this
area in older patients using echocardiography.
The ideas behind these catheter-based methods and the
remarkable technological developments have opened an
exciting new frontier for the nonsurgical treatment of
patients with a wide array of congenital and acquired
cardiac malformations. Although the short- and medium-
term results have been nothing short of spectacular, a
word of caution seems appropriate. Placement of some of
these devices requires a foreign body to be exposed to the
left heart circulation. Although we believe that endothe-
lialization will minimize or eliminate the risk of a sub-
sequent untoward event, it remains to be seen if this is the
case. It is certainly encouraging that the patient reported
herein has done well for a year following occlusion of the
fistula. It is, however, incumbent on all of us who utilize
these techniques to follow these patients for the foresee-
able future and report any untoward events that might be
related to treatment utilizing a device.
Undoubtedly, new techniques in the years to come
will provide even more exciting treatment modalities
for these patients. We have already eliminated surgery
as the treatment of choice for some forms of cardiac
malformations, such as patent ductus arteriosus and
secundum atrial septal defect. Surgery for ventricular
septal defects may not be far behind. As treatment
evolves for even more complex lesions, the number of
patients requiring surgical intervention will slowly
decrease, and this will have an impact on surgical
experience. As the years go by, one wonders what will
be left for the surgeons?
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